# Novo Nordisk to begin 2024 share buybacks
Published: 2024-02-06
Category: News
Category URL: https://technologydispatch.com/category/news/
Meta Title: Novo Nordisk initiates 2024 share buyback program
Meta Description: Danish maker Novo Nordisk to execute its planned share repurchase program, including obesity drug Wegovy and diabetes treatment Ozempic.
URL: https://technologydispatch.com/novo-nordisk-to-begin-2024-share-buybacks/

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qslpr5001pwirgs7x8860d/images/2024-02-06t074923z2lynxmpek1507irtroptp4novo-nordisk-results-wegovy-strategy-1737022165164-compressed.jpg)

## Novo Nordisk to begin 2024 share buybacks

OSLO (Reuters) – Novo Nordisk will on Tuesday begin the execution of its planned share buyback programme for 2024, the Danish maker of obesity drug Wegovy and diabetes treatment Ozempic said in a statement.

Novo on Jan. 31 said it planned to carry out a share repurchase plan of up to 20 billion Danish crowns ($2.88 billion) to reduce the company’s share capital and to meet obligations arising from share-based incentive programmes.

The company completed its previous 12-month share repurchase programme on Jan. 30.

($1 = 6.9337 Danish crowns)

(Reporting by Terje Solsvik, editing by Anna Ringstrom and Essi Lehto)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---